BEST UNLIMITED TURBO LONG CERTIFICATE - IPSEN | Market Closed - Euronext Paris 10:00:00 03/05/2024 pm IST | ||
| 2.225 EUR | -1.77% |
|
| Current month | +0.45% | ||
| 1 month | +18.77% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/24/03 | 2.215 | -2.21% | 33 |
| 02/24/02 | 2.265 | +2.72% | 47 |
| 30/24/30 | 2.205 | +4.75% | 60 |
| 29/24/29 | 2.105 | -2.77% | 40 |
| 26/24/26 | 2.165 | +2.36% | 36 |
Real-time Euronext Paris
Last update May 03, 2024 at 10:00 pm IST
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 34S7S | |
| ISIN | DE000SD3MHE0 |
| Date issued | 05/02/2021 |
| Strike | 70.52 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 0.76 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.245 € |
|---|---|
| Lowest since issue | 0.34 € |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
114.5
EUR
Average target price
125.5
EUR
Spread / Average Target
+9.63%
- Stock Market
- Certificates
- 34S7S Certificat
